Oncotelic Therapeutics enters securities purchase agreement for $178,410
Oncotelic Therapeutics entered a securities purchase agreement with Pacific Pier Capital II, LLC to sell a promissory note. This issuance of 500,000 common stock shares indicates the company is securing external funding.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day